S L Woolley1, D R K Smith, S Quine. 1. Emergency Department, Bristol Royal Infirmary, University Hospital of Wales, Cardiff, Wales, UK. sarah.woolley@ubht.nhs.uk
Abstract
OBJECTIVE: We report an adult case of cystic lymphangioma treated with OK-432 (Picibanil). METHOD: A case report and review of the literature concerning the use of OK-432 to treat cystic lymphangioma is presented. RESULTS: A 31-year-old woman developed a cystic lymphangioma four weeks post-partum. This was treated initially by aspiration, for diagnostic purposes. Investigation suggested that surgery would be challenging. A review of the literature demonstrated success with OK-432 in the treatment of this condition, although primarily in the paediatric population. This patient was successfully treated thus, and at the time of writing remained symptom free. A suggested management plan is outlined. CONCLUSION: Treatment with OK-432 is useful in the management of cystic lymphangiomas in adults and should be considered as first line treatment.
OBJECTIVE: We report an adult case of cystic lymphangioma treated with OK-432 (Picibanil). METHOD: A case report and review of the literature concerning the use of OK-432 to treat cystic lymphangioma is presented. RESULTS: A 31-year-old woman developed a cystic lymphangioma four weeks post-partum. This was treated initially by aspiration, for diagnostic purposes. Investigation suggested that surgery would be challenging. A review of the literature demonstrated success with OK-432 in the treatment of this condition, although primarily in the paediatric population. This patient was successfully treated thus, and at the time of writing remained symptom free. A suggested management plan is outlined. CONCLUSION: Treatment with OK-432 is useful in the management of cystic lymphangiomas in adults and should be considered as first line treatment.